DTIL
Income statement / Annual
Last year (2023), Precision BioSciences, Inc.'s total revenue was $48.73 M,
an increase of 94.15% from the previous year.
In 2023, Precision BioSciences, Inc.'s net income was -$61.32 M.
See Precision BioSciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$48.73 M
|
$25.10 M
|
$115.53 M
|
$24.29 M
|
$22.24 M
|
$10.88 M
|
$6.48 M
|
$7.02 M
|
| Cost of Revenue |
$8.26 M |
$9.00 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$40.47 M |
$16.09 M |
$115.53 M |
$24.29 M |
$22.24 M |
$10.88 M |
$6.48 M |
$7.02 M |
| Gross Profit Ratio |
0.83 |
0.64 |
1 |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$53.38 M
|
$83.94 M
|
$115.24 M
|
$98.06 M
|
$82.42 M
|
$45.12 M
|
$20.32 M
|
$9.10 M
|
| General & Administrative
Expenses |
$39.09 M
|
$41.53 M
|
$39.69 M
|
$36.05 M
|
$27.03 M
|
$13.67 M
|
$8.02 M
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$39.09 M
|
$41.53 M
|
$39.69 M
|
$36.05 M
|
$27.03 M
|
$13.67 M
|
$8.02 M
|
$6.10 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$9.76 M |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$92.46 M |
$125.46 M |
$154.93 M |
$134.11 M |
$109.44 M |
$58.80 M |
$28.34 M |
$15.20 M |
| Cost And Expenses |
$92.46 M |
$125.46 M |
$154.93 M |
$134.11 M |
$109.44 M |
$58.80 M |
$28.34 M |
$15.84 M |
| Interest Income |
$7.69 M |
$3.47 M |
$208,000.00 |
$822,000.00 |
$4.27 M |
$1.88 M |
$872,000.00 |
$570,000.00 |
| Interest Expense |
$2.23 M |
$1.11 M |
$132,000.00 |
$0.00 |
$182,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$8.26 M
|
$9.00 M
|
$10.20 M
|
$9.81 M
|
$5.32 M
|
$2.35 M
|
$1.44 M
|
$640,000.00
|
| EBITDA |
-$32.04 M
|
-$62.79 M
|
-$20.27 M
|
-$99.19 M
|
-$87.38 M
|
-$43.68 M
|
-$20.42 M
|
-$8.19 M
|
| EBITDA Ratio |
-0.66 |
-3.92 |
-0.25 |
-4.08 |
-3.93 |
-4.19 |
-3.13 |
-1.17 |
| Operating Income Ratio
|
-0.9
|
-4
|
-0.34
|
-4.52
|
-3.92
|
-4.4
|
-3.39
|
-1.26
|
| Total Other
Income/Expenses Net |
$1.21 M
|
$27.46 M
|
$8.80 M
|
$822,000.00
|
-$5.67 M
|
$1.88 M
|
$872,000.00
|
$572,000.00
|
| Income Before Tax |
-$42.53 M |
-$111.64 M |
-$30.60 M |
-$109.01 M |
-$92.88 M |
-$46.04 M |
-$21.10 M |
-$8.26 M |
| Income Before Tax Ratio
|
-0.87
|
-4.45
|
-0.26
|
-4.49
|
-4.18
|
-4.23
|
-3.25
|
-1.18
|
| Income Tax Expense |
$0.00 |
$11.27 M |
$316,000.00 |
$10.43 M |
-$9.58 M |
$1.88 M |
-$754,000.00 |
-$5,000.00 |
| Net Income |
-$61.32 M |
-$122.91 M |
-$30.92 M |
-$109.01 M |
-$83.30 M |
-$46.04 M |
-$21.10 M |
-$8.25 M |
| Net Income Ratio |
-1.26 |
-4.9 |
-0.27 |
-4.49 |
-3.75 |
-4.23 |
-3.25 |
-1.18 |
| EPS |
-15.96 |
-41.95 |
-15.8 |
-62.85 |
-59.5 |
-28.17 |
-18.81 |
-0.0049 |
| EPS Diluted |
-15.96 |
-41.95 |
-15.8 |
-62.85 |
-59.5 |
-28.17 |
-18.81 |
-0.0049 |
| Weighted Average Shares
Out |
$3.84 M
|
$2.93 M
|
$1.96 M
|
$1.73 M
|
$1.40 M
|
$1.63 M
|
$1.12 M
|
$1.67 B
|
| Weighted Average Shares
Out Diluted |
$3.84 M
|
$2.93 M
|
$1.96 M
|
$1.73 M
|
$1.40 M
|
$1.63 M
|
$1.12 M
|
$1.67 B
|
| Link |
|
|
|
|
|
|
|
|
